Open session of the standing technical committee of the EUFMD- 2004

Page 463

Appendix 75 Diagnostic Tools for Epidemiological Surveillance in South America Ingrid Bergmann*, Viviana Malirat, Erika Neitzert Pan American Foot-and-Mouth Disease Center (PAFMDC) Reappearance of FMDV in the FMD-free regions of the Southern-Cone of South-America in 2000-2001 prompted the need to understand the putative origin of these emergencies. Thus, efforts were oriented to identify genetic links among strains, through the constitution of a genetic database by the PAFMDC, including viruses recorded in endemic regions, and during the emergencies. The phylogenetic analysis placed all emergency isolates in a single lineage together with viruses previously circulating in the Southern Cone, or currently appearing in high-risk zones with sporadic disease (“hot spots”) of this subregion. No evident link could be established among these isolates and lineages including viruses from the Andean subregion, reflecting two independent production systems and livestock trade circuits. Further studies were oriented to identify the source of infection. Potentially the episodes could have originated from “hot spots” within the subregion or from persistent infection in areas already declared FMD-free. In this context, serosurveillance of viral circulation through an immunoenzymatic system (screening ELISA-3ABC and confirmatory EITB), developed and validated at PAFMDC, constituted an important adjunct, particularly using the criteria for assessing risk of viral circulation in a population (age stratification, graphic displays, multifactorial analysis, etc), identified after its extensive use in SouthAmerica. Follow-up of serosurveys in the Southern-Cone during advanced stages of the eradication programs strongly indicated clearance of viral circulation shortly after last episodes. This was reinforced by the lack of outbreaks in these areas even for many years after suspension of vaccination, indicating that reappearance of disease was not due to a carrier capable of causing an episode. Moreover, the use of this system in longitudinal studies to follow-up viral activity after emergencies, demonstrated clearance of viral circulation shortly after the episodes, again reinforcing the observation that if carriers exist they do not play a significant role for maintenance of FMD, at least under the epidemiological circumstances of the areas studied. Based on these observations, reintroductions of FMD most probably occurred from trade activities involving “hot spots”, within the subregion.

454


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Appendix 82

17min
pages 492-500

Appendix 77

22min
pages 468-476

Appendix 78

25min
pages 477-484

Appendix 79

14min
pages 485-489

Appendix 81

1min
page 491

Appendix 80

1min
page 490

Appendix 76

12min
pages 464-467

Appendix 75

1min
page 463

Appendix 64

10min
pages 412-414

Appendix 72

13min
pages 455-460

Appendix 73

1min
page 461

Appendix 65

1min
page 415

Appendix 67

1min
page 424

Appendix 63

34min
pages 401-411

Appendix 62

2min
page 400

Appendix 54

8min
pages 361-363

Appendix 61

15min
pages 394-399

Appendix 55

11min
pages 364-366

Appendix 59

1min
page 385

Appendix 60

20min
pages 386-393

Appendix 56

1min
page 367

Appendix 42

21min
pages 270-276

Appendix 52

10min
pages 350-352

Appendix 50

21min
pages 330-339

Appendix 46

2min
page 307

Appendix 37

7min
pages 241-243

Appendix 38

7min
pages 244-246

Appendix 41

2min
page 269

Appendix 40

15min
pages 255-268

Appendix 36

16min
pages 236-240

Appendix 35

15min
pages 231-235

Appendix 34

25min
pages 224-230

Appendix 28

2min
page 198

Appendix 31

10min
pages 212-215

Appendix 29

16min
pages 199-203

Appendix 33

3min
pages 221-223

Appendix 27

1min
page 197

Appendix 26

27min
pages 188-196

Appendix 25

12min
pages 182-187

Appendix 23

8min
pages 168-171

Appendix 22

28min
pages 158-167

Appendix 15

2min
page 113

Appendix 16

7min
pages 114-116

Appendix 20 EMEA paper extract - Recommendations for tests for induction of antibodies to NSP antigens by FMD vaccines

4min
pages 144-145

Appendix 19

18min
pages 136-143

Appendix 14

4min
page 112

Appendix 13

10min
pages 107-111

Appendix 5

2min
page 64

Appendix 12

9min
pages 104-106

Appendix 3

9min
pages 47-49

Appendix 4

26min
pages 50-63

Appendix 8

12min
pages 77-80

Appendix 2

8min
pages 43-46

Open Session

6min
pages 39-42

Closed Session

2min
pages 37-38

Item 11 – Persistent and subclinical infections – diagnostic and surveillance issues

3min
page 33

Item 15 – Managing the decision-making process in control of FMD and in the priority setting of research and development

3min
page 36

Item 14 – Regulatory compliance

2min
page 35

Item 10 – International issues

3min
page 32

Item 9 – Novel vaccines

3min
page 31

Item 7 – Optimisation of conventional vaccines

3min
page 29

Item 4 – Managing diagnostic demands

3min
page 27

Item 8 – Regulatory issues affecting FMD vacine selection and use

3min
page 30

Item 3 – Transmission and its control

3min
page 26

3.4.2 Post-vaccination serosurveillance (PVS) for presence of FMD infected animals

3min
page 16

Item 1 – Recent findings in molecular epidemiology of FMDV

3min
page 24

Item 2 – Surveillance: for what purpose and how much is enough?

3min
page 25

4.2 Collection of sera/specimens for validation of DIVA tests for detection of animals received from SAT virus infection

3min
page 20
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.